Genpact to Provide AI Capabilities to GE HealthCare
By Stephen Nakrosis
Genpact said it entered a new multi-year agreement which will see it provide resources to help GE HealthCare manage its U.S. leasing and lending operations.
The deal will see GE HealthCare leverage Genpact's business-process-as-a-service operating model to strengthen capabilities for customers acquiring new medical equipment, the companies said.
"The BPaaS operating model is integrated with Genpact's AI-powered platform, Genpact Cora, offering a scalable and agile solution to help meet the company's needs," Genpact said. The model has an open architecture, which integrates generative AI and other emerging digital technologies, the company added.
Write to Stephen Nakrosis at stephen.nakrosis@wsj.com
(END) Dow Jones Newswires
August 22, 2023 17:06 ET (21:06 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
Eli Lilly Earnings: Strong Weight-Loss Drug Sales Expand Margins
-
What the Fed’s QT Program Is, and Why Its End Matters
-
After Earnings, Is Meta Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is Boeing Stock a Buy, a Sell, or Fairly Valued?
-
The 10 Best Companies to Invest in Now
-
Paramount Earnings: CEO Has Gone, For-Sale Sign Is Up; Good Results Would’ve Been Nice to Learn
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?